Who owns GALMED PHARMACEUTICALS LTD?
- Ticker: GLMD
- CUSIP Number: m47238122
Tip: Access positions for across all investors
Analyze quarterly positions in Galmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Galmed Pharmaceuticals stock
Who bought or sold GALMED PHARMACEUTICALS LTD this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
CVI Holdings | 75k | $25k | -70% | Mar 2024 |
|
Walleye Trading Advisors | 42k | $14k | -64% | Mar 2024 |
|
Two Sigma Advisers | 22k | $7.7k | -50% | Mar 2024 |
|
Two Sigma Securities | 16k | $5.6k | 100% | Mar 2024 |
|
Morgan Stanley | 15k | $5.0k | -28% | Mar 2024 |
|
UBS Group | 2.3k | $781.960000 | 100% | Mar 2024 |
|
Wells Fargo & Company | 204.00 | $70.992000 | 0% | Mar 2024 |
|
TSFG | 200.00 | $0 | 0% | Mar 2024 |
|
Federation des caisses Desjardins du Quebec | 167.00 | $57.999100 | 100% | Mar 2024 |
|
Advisor Group Holdings | 53.00 | $17.998800 | 0% | Mar 2024 |
|
Hanson McClain Advisors | 17.00 | $5.999300 | 0% | Mar 2024 |
|
Zrc Wealth Management | 7.00 | $3.000200 | 0% | Mar 2024 |
|
Bank of America Corporation | 1.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Galmed Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Two Sigma Investments | Dec 2023 | 24k | $11k |
Citadel Advisors | Dec 2023 | 11k | $5.1k |
Bourgeon Capital Management | Dec 2023 | 34.00 | $16.000400 |